As of 2025-07-01, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (48.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.71 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -1419.3%.
The range of the Relative Valuation is (48.68) - (67.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 17.7x | 12.6x |
| Forward P/E multiples | 12.8x - 20.1x | 13.1x |
| Fair Price | (48.68) - (67.35) | (48.95) |
| Upside | -1412.1% - -1915.2% | -1419.3% |
| Date | P/E |
| 2025-06-27 | -1.01 |
| 2025-06-26 | -1.07 |
| 2025-06-25 | -1.07 |
| 2025-06-24 | -1.05 |
| 2025-06-23 | -0.99 |
| 2025-06-20 | -1.08 |
| 2025-06-18 | -1.07 |
| 2025-06-17 | -1.09 |
| 2025-06-16 | -1.15 |
| 2025-06-13 | -1.15 |
| 2025-06-12 | -1.18 |
| 2025-06-11 | -1.14 |
| 2025-06-10 | -1.17 |
| 2025-06-09 | -1.26 |
| 2025-06-06 | -1.14 |
| 2025-06-05 | -1.03 |
| 2025-06-04 | -1.01 |
| 2025-06-03 | -1.02 |
| 2025-06-02 | -0.98 |
| 2025-05-30 | -0.95 |
| 2025-05-29 | -0.97 |
| 2025-05-28 | -0.91 |
| 2025-05-27 | -0.90 |
| 2025-05-23 | -0.92 |
| 2025-05-22 | -0.95 |
| 2025-05-21 | -0.93 |
| 2025-05-20 | -1.01 |
| 2025-05-19 | -1.00 |
| 2025-05-16 | -0.90 |
| 2025-05-15 | -0.84 |
| 2025-05-14 | -0.82 |
| 2025-05-13 | -0.86 |
| 2025-05-12 | -0.87 |
| 2025-05-09 | -0.81 |
| 2025-05-08 | -0.85 |
| 2025-05-07 | -0.82 |
| 2025-05-06 | -0.81 |
| 2025-05-05 | -0.94 |
| 2025-05-02 | -0.99 |
| 2025-05-01 | -0.90 |
| 2025-04-30 | -0.88 |
| 2025-04-29 | -0.85 |
| 2025-04-28 | -0.88 |
| 2025-04-25 | -0.88 |
| 2025-04-24 | -0.85 |
| 2025-04-23 | -0.90 |
| 2025-04-22 | -0.89 |
| 2025-04-21 | -0.81 |
| 2025-04-17 | -0.80 |
| 2025-04-16 | -0.76 |